Illuminate Hypersomnia Adjunct Scientific Meeting
Tackling Drug Development Challenges for Idiopathic Hypersomnia
On February 13, 2025, from 12-2 pm Eastern Time, Sleep Consortium hosted the Illuminate Hypersomnia Adjunct Scientific Meeting. This virtual scientific session addressed critical challenges in drug development for idiopathic hypersomnia (IH), as identified during the groundbreaking Illuminate Hypersomnia Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting held on April 11, 2024.
The Illuminate Hypersomnia Adjunct Scientific Meeting brought together experts in the fields of sleep medicine, pharmaceutical research, regulatory science, medical affairs, and patient advocacy. Presenters and panelists focused on collaborative efforts to overcome key scientific and drug development hurdles in the development of effective treatments for idiopathic hypersomnia.
The Illuminate Hypersomnia Adjunct Scientific Meeting brought together experts in the fields of sleep medicine, pharmaceutical research, regulatory science, medical affairs, and patient advocacy. Presenters and panelists focused on collaborative efforts to overcome key scientific and drug development hurdles in the development of effective treatments for idiopathic hypersomnia.
Watch the Adjunct Scientific Meeting Recording
View the meeting program, including the agenda, speakers, and discussion questions
Thank you to the organizations who have partnered with us for the Illuminate Hypersomnia initiative:
(Host organization)
Thank you to these generous sponsors for unrestricted educational grants in support of the Illuminate Hypersomnia Adjunct Scientific Meeting:
For questions or more information about the Illuminate Hypersomnia Adjunct Scientific Meeting, reach out to us via email at PFDD@sleepconsortium.org.